Alembic Pharmaceuticals informs about Press Release

27 Mar 2019 Evaluate

Alembic Pharmaceuticals has informed about press release regarding the Company received US Food & Drug Administration (USFDA) Approval for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1121.40 -7.35 (-0.65%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.